Cyclophosphamide Capsule
Product Images NDC 62332-618

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 62332-618). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 Capsules (Cyclophosphamide mg 25)

Each capsule contains 25 mg of Cyclophosphamide USP. The usual dosage and complete prescribing information can be found on the package insert. The capsules should be swallowed whole and should not be opened, chewed, or crushed. This is a cytotoxic agent and should be stored at room temperature. The package contains 100 capsules and is child-resistant. It should be dispensed in a light-resistant container according to the USPNF.*

FDA Label Image

100 Capsules (Cyclophosphamide mg 50)

Each capsule of Cyclophosphamide USP contains 50mg of Cydophasphamide to be swallowed whole without opening, chewing or crushing. The usual dosage can be found in the package insert. The capsules should be stored at a temperature of 20°C to 25°C and excursions to between 15°C to 30°C are allowed. Gloves should be worn when handling both containers and capsules. This is a cytotoxic agent and should be handled with care. Dispense in a tight container and keep away from children. The manufacturer is Alembicy and the package insert references code 01801.*

FDA Label Image

Cyclophosphamide-str.jpg (Cyclophosphamide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.